1. Urine CD163 is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis
- Author
-
Yun Ju Huang, Chiung-Hung Lin, Yang Huang-Yu, Shue-Fen Luo, and Chang-Fu Kuo
- Subjects
immune system diseases ,skin and connective tissue diseases - Abstract
Objectives Urine soluble CD163 (usCD163) is released from alternatively activated macrophages involved in the resolution of inflammation in glomeruli, and plays an important role in glomerulonephritis. This study explored the role of usCD163 in patients with systemic lupus erythematosus (SLE). Methods usCD163 concentrations were measured cross-sectionally in 261 SLE patients. Clinical and laboratory data were collected, and SLE disease activity scores were calculated to assess the correlation with usCD163. Results SLE patients with high usCD163 levels tended to be younger, with a higher hospital admission rate, higher prednisolone dose, lower estimated glomerular filtration rate, higher urine protein creatinine ratio (UPCR), more pyuria and hematuria, higher levels of inflammatory markers, higher rates of anemia, neutropenia, and lymphopenia, lower complement 3 (C3) levels, higher anti-double stranded DNA antibody (anti-dsDNA Ab) levels, and higher disease activity scores (p
- Published
- 2022
- Full Text
- View/download PDF